This company listing is no longer active
Salud financiera de hoja de balance de Taiwan Leader Biotech
Salud financiera controles de criterios 5/6
Información clave
27.2%
Ratio deuda-patrimonio
NT$63.63m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | NT$36.75m |
| Patrimonio | NT$234.01m |
| Total pasivo | NT$86.89m |
| Activos totales | NT$320.91m |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: 8490's short term assets (NT$148.4M) exceed its short term liabilities (NT$26.0M).
Pasivo a largo plazo: 8490's short term assets (NT$148.4M) exceed its long term liabilities (NT$60.9M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 8490's net debt to equity ratio (11.5%) is considered satisfactory.
Reducción de la deuda: 8490's debt to equity ratio has increased from 16.2% to 27.2% over the past 5 years.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: 8490 has sufficient cash runway for more than a year based on its current free cash flow.
Pronóstico de cash runway: 8490 has sufficient cash runway for 1.5 years if free cash flow continues to grow at historical rates of 26% each year.